Cardinal Health Extends Distribution Agreement with CVS Health Until 2032
Cardinal Health has entered into a binding Letter of Intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extension maintains the current scope of services Cardinal Health provides under their existing partnership. CEO Jason Hollar emphasized the value of this long-standing relationship and highlighted continued collaboration aimed at serving customers effectively. In conjunction with the renewal announcement, Cardinal Health reaffirmed its fiscal year 2027 non-GAAP EPS guidance for growth between 13% to 15%, projecting a range of $12.40 to $12.60 per share. The company also reiterated its long-term non-GAAP EPS growth rate target of 12% to 14%. Further details are expected during the first quarter earnings call on November 5, 2026.
Topics: contract renewal EPS guidance pharmaceutical distribution